Methods of treatment of glaucoma and other conditions mediated by nos-2 expression via inhibition of the egfr pathway
作者： Arthur H. Neufeld , Bin Liu
DOI:
关键词:
摘要: Therapeutic methods and compositions for the treatment of glaucoma other conditions mediated at least in part by expression NOS-2 are provided.
lens.org 参考文章(20)
M. Flint Beal, Methods of inhibiting neurodegerative diseases ,(1998)
Felix Theeuwes, Microporous-semipermeable laminated osmotic system ,(1979)
Felix Theeuwes, Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina ,(1977)
Peter John Whittle, John Adams Lowe, 6-phenylpyridyl-2-amine derivatives ,(1997)
Hugues Lafontaine, Derek C. Houghton, Method of producing a SI-GE base heterojunction bipolar device ,(2001)
Irving M. Katz, Contact lens wetting agents ,(1979)
Evangelia Vakalopoulou, Mathias Schmidt, Douglas W. Schneider, Winfried S. Wels, Epidermal growth factor receptor antibodies ,(1999)
Krzysztof Biniecki, Lech Kozerski, Aleksander P. Mazurek, Derivatives of genistein ,(1996)
Michael Robert Jirousek, Gary Lowell Engel, Nagy Alphonse Farid, Leonard Larry Winneroski, Lori Ann Richardson, Margaret Mary Faul, Protein kinase C inhibitor ,(1996)
Marie-Claire Friteyre, Claude Mazuel, Ophthalmological composition of the type which undergoes liquid-gel phase transition ,(1986)